Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families

Arthritis Research and Therapy

Volumn 18, Issue 1, 2016, Pages

  Kuo, Chang Fu ^a,b   Luo, Shue Fen ^b   Yu, Kuang Hui ^b   See, Lai Chu ^c   Zhang, Weiya ^a   Doherty, Michael ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Familial aggregation; Familial transmission; Relative risk; Rheumatic diseases; Systemic sclerosis

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; ENVIRONMENTAL FACTOR; FEMALE; FIRST-DEGREE RELATIVE; GENEALOGY; GENETIC COUNSELING; GENETIC RISK; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MYOSITIS; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PSORIASIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; TAIWAN; AGED; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION; GENETICS; SCLERODERMA, SYSTEMIC;

ADULT; AGED; AUTOIMMUNE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RISK FACTORS; SCLERODERMA, SYSTEMIC; TAIWAN;

EID: 84990879099     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-016-1127-6     Document Type: Article

References (35)

1. Mayes MD, Lacey Jr JV, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, Schottenfeld D. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48(8):2246-55.
2. Yu KH, See LC, Kuo CF, Chou IJ, Chou MJ. Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care Res (Hoboken). 2013;65(2):244-50.
3. Kuo CF, See LC, Yu KH, Chou IJ, Tseng WY, Chang HC, Shen YM, Luo SF. Epidemiology and mortality of systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2011;40(5):373-8.
4. Kuo CF, Luo SF, Yu KH, Chou IJ, Tseng WY, Chang HC, Fang YF, Chiou MJ, See LC. Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan. Scand J Rheumatol. 2012;41(1):44-9.
5. Agarwal SK, Tan FK, Arnett FC. Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am. 2008;34(1):17-40. v.
6. Englert H, Small-McMahon J, Chambers P, O'Connor H, Davis K, Manolios N, White R, Dracos G, Brooks P. Familial risk estimation in systemic sclerosis. Aust N Z J Med. 1999;29(1):36-41.
7. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, Mayes MD. Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum. 2001;44(6):1359-62.
8. Mayes MD. The genetics of scleroderma: looking into the postgenomic era. Curr Opin Rheumatol. 2012;24(6):677-84.
9. Alarcon-Segovia D, Alarcon-Riquelme ME, Cardiel MH, Caeiro F, Massardo L, Villa AR, Pons-Estel BA, Grupo Latinoamericano de Estudio del Lupus E. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005;52(4):1138-47.
10. Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol. 2015;11(11):649-62.
11. Kuo CF, Grainge MJ, Valdes AM, See LC, Luo SF, Yu KH, Zhang W, Doherty M. Familial risk of Sjogren's syndrome and co-aggregation of autoimmune diseases in affected families: a nationwide population study. Arthritis Rheumatol. 2015;67(7):1904-12.
12. The National Health Insurance Statistics, 2010. http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu_id=296&webdata_id=1942&WD_ID=296. Accessed 5 Sept 2016.
13. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 1990;46(2):222-8.
14. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21(2):302-6.
15. Lee J, Chia KS. Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Br J Ind Med. 1993;50(9):861-2.
16. Lin DY. Cox regression analysis of multivariate failure time data: the marginal approach. Stat Med. 1994;13(21):2233-47.
17. Lichtenstein P, Yip BH, Bjork C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373(9659):234-9.
18. Liu CYHY, Chuang YL, Chen YJ, Weng WS, Liu JS, Liang KY. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag. 2006;14:1-22.
19. Falconer DS. The inheritance of liability to diseases with variable age of onset, with particular reference to diabetes mellitus. Ann Hum Genet. 1967;31(1):1-20.
20. Reich T, James JW, Morris CA. The use of multiple thresholds in determining the mode of transmission of semi-continuous traits. Ann Hum Genet. 1972;36(2):163-84.
21. Reich T, Rice J, Cloninger CR, Wette R, James J. The use of multiple thresholds and segregation analysis in analyzing the phenotypic heterogeneity of multifactorial traits. Ann Hum Genet. 1979;42(3):371-90.
22. Yang J, Visscher PM, Wray NR. Sporadic cases are the norm for complex disease. Eur J Hum Genet. 2010;18(9):1039-43.
23. Koumakis E, Dieude P, Avouac J, Kahan A, Allanore Y, Association des Sclerodermiques de F. Familial autoimmunity in systemic sclerosis-results of a French-based case-control family study. J Rheumatol. 2012;39(3):532-8.
24. Hudson M, Rojas-Villarraga A, Coral-Alvarado P, Lopez-Guzman S, Mantilla RD, Chalem P, Canadian Scleroderma Research G, Colombian Scleroderma Research G, Baron M, Anaya JM. Polyautoimmunity and familial autoimmunity in systemic sclerosis. J Autoimmun. 2008;31(2):156-9.
25. Cook NJ, Silman AJ, Propert J, Cawley MI. Features of systemic sclerosis (scleroderma) in an identical twin pair. Br J Rheumatol. 1993;32(10):926-8.
26. De Keyser F, Peene I, Joos R, Naeyaert JM, Messiaen L, Veys EM. Occurrence of scleroderma in monozygotic twins. J Rheumatol. 2000;27(9):2267-9.
27. Zhou X, Tan FK, Xiong M, Arnett FC, Feghali-Bostwick CA. Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles. Arthritis Rheum. 2005;52(10):3305-14.
28. Feghali-Bostwick C, Medsger Jr TA, Wright TM. Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies. Arthritis Rheum. 2003;48(7):1956-63.
29. Soppi E, Lehtonen A, Toivanen A. Familial progressive systemic sclerosis (scleroderma): immunological analysis of two patients and six siblings from a single kindred. Clin Exp Immunol. 1982;50(2):275-82.
30. Greger RE, Greger RE. Familial progressive systemic scleroderma. Arch Dermatol. 1975;111(1):81-5.
31. Frayha RA, Tabbara KF, Geha RS. Familial CRST syndrome with sicca complex. J Rheumatol. 1977;4(1):53-8.
32. Frech T, Khanna D, Markewitz B, Mineau G, Pimentel R, Sawitzke A. Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study. Arthritis Rheum. 2010;62(7):2109-16.
33. Cherkas LF, Williams FM, Carter L, Howell K, Black CM, Spector TD, MacGregor AJ. Heritability of Raynaud's phenomenon and vascular responsiveness to cold: a study of adult female twins. Arthritis Rheum. 2007;57(3):524-8.
34. Arora-Singh RK, Assassi S, del Junco DJ, Arnett FC, Perry M, Irfan U, Sharif R, Mattar T, Mayes MD. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun. 2010;35(1):52-7.
35. Horimoto AM, Silveira AF, da Costa IP. Familial autoimmunity and polyautoimmunity in 60 Brazilian Midwest patients with systemic sclerosis. Rev Bras Reumatol Engl Ed. 2016;56(4):314-22.